Executive Summary
Generated July 30, 2026
Cybersecurity
Cellebrite
Strategic importance is our editorial rating of how central this entity is to the technology landscape we track; confidence reflects how well-sourced and current the underlying evidence is.
1
Chokepoint Score
1 other entity structurally depend on this one
Steady
Momentum
insider filing activity unchanged since last check
Headquarters
Petah Tikva, Israel
Website
Employees
1,100 (2026, approximate)
Founded
1999
Listing
CLBT · NASDAQ
Market Cap
$3.70B
Revenue (TTM)
$496.43M
Price
USD14.85 (+0.68%)
Market data as of Jul 29, 2026, 11:25 AM · Source: Yahoo Finance (delayed). Not investment advice.
Overview
An Israeli digital forensics company providing mobile device forensics and investigative intelligence software used by law enforcement and enterprises, including AI and drone forensics capabilities. Q1 2026 revenue rose 19% year-over-year to $128.3 million, with annual recurring revenue reaching $493 million, up 21% and trailing-twelve-month free cash flow of $158.6 million (32% margin); the company closed its acquisition of drone-forensics specialist SCG Canada in March 2026 and guides to full-year 2026 revenue of $565-571 million.
Strategic Connections
- AI-Native Cybersecurity: Cellebrite has expanded its digital forensics portfolio with AI and drone forensics capabilities amid surging demand for digital investigation tools.
- Government, Defense & Public Sector: Cellebrite supplies digital forensics tools used by law enforcement and government agencies within the government, defense and public sector.
Strategic Risks
- Reputational and regulatory scrutiny risk given law-enforcement-focused surveillance/forensics use cases
Future Outlook
- AI-driven investigative tooling and drone forensics expected to be continued growth areas
- SCG Canada acquisition expands total addressable market into drone-based digital evidence collection
Sources
4 sources, 68% average source confidence — full citations in the Full Analyst Report.
Generated by InsightNodes — Technology Intelligence Platform. This report reflects sourced, evidence-backed information as of the dates cited above and is not investment advice.
Viewing the Executive Summary — switch to the Full Analyst Report.